MEDIGUS LTD's ticker is MDGSW and the CUSIP is 58471G128. A total of 8 filers reported holding MEDIGUS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -68.2% | 28,450 | -50.0% | 0.00% | – |
| Q1 2022 | $22,000 | +144.4% | 56,900 | +208.4% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | -52.6% | 18,450 | -43.9% | 0.00% | -75.0% |
| Q2 2021 | $19,000 | -40.6% | 32,900 | -11.1% | 0.00% | -63.6% |
| Q1 2021 | $32,000 | +220.0% | 37,000 | -31.5% | 0.01% | +450.0% |
| Q4 2020 | $10,000 | – | 54,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,285,715 | $634,000 | 0.02% |
| Anson Funds Management LP | 21,000 | $29,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 544,940 | $93,000 | 0.01% |
| CVI Holdings, LLC | 57,986 | $10,000 | 0.00% |
| EQUITEC SPECIALISTS, LLC | 30,040 | $5,000 | 0.00% |
| UBS Group AG | 3,101 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |